Wave Life Sciences Ltd. (WVE)
8.07
-0.55 (-6.38%)
At close: Mar 31, 2025, 2:00 PM
Wave Life Sciences Ltd. Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 108.3M | 113.31M | 3.65M | 40.96M | 20.08M | 15.98M | 14.41M | 3.7M | 1.49M | 152K | n/a | n/a |
| Cost of Revenue | n/a | 9.21M | 10.11M | 121.88M | 124.17M | 175.43M | 134.43M | 79.31M | 393K | 9.06M | 2.4M | 4.61M |
| Gross Profit | 108.3M | 104.1M | -6.46M | -80.91M | -104.09M | -159.45M | -120.01M | -75.61M | 1.09M | -8.9M | -2.4M | -4.61M |
| Operating Income | -110.4M | -68M | -162.72M | -127.02M | -153.38M | -208.32M | -159.52M | -102.58M | -55.33M | -19.3M | -5.39M | -3.57M |
| Interest Income | n/a | 7.93M | n/a | 30K | 568K | 4.94M | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -97.01M | -58.19M | -161.14M | -122.45M | -150.75M | -193.64M | -146.58M | -101.33M | -54.78M | -19.16M | -5.14M | -3.65M |
| Net Income | -97.01M | -57.51M | -161.82M | -122.25M | -149.91M | -179.5M | -146.65M | -102.03M | -55.4M | -19.2M | -5.23M | -3.32M |
| Selling & General & Admin | 59.02M | 51.29M | 50.51M | 46.1M | 42.51M | 48.87M | 39.51M | 26.98M | 15.99M | 10.39M | 3M | 1.65M |
| Research & Development | 159.68M | 130.01M | 115.86M | 121.88M | 130.94M | 175.43M | 134.43M | 79.31M | 40.82M | 9.06M | 2.4M | 1.92M |
| Other Expenses | n/a | n/a | 7K | 4.54M | 2.06M | 9.74M | 9.55M | -331K | -50K | 56K | 261K | 37K |
| Operating Expenses | 218.71M | 181.3M | 166.37M | 167.98M | 173.45M | 224.3M | 173.94M | 106.28M | 56.81M | 19.45M | 5.39M | 3.57M |
| Interest Expense | n/a | n/a | n/a | n/a | 16K | n/a | 22K | 6K | 337K | 86K | 12K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 218.71M | 181.3M | 166.37M | 167.98M | 173.45M | 224.3M | 173.94M | 106.28M | 56.81M | 19.45M | 5.39M | 3.57M |
| Income Tax | n/a | -677K | 681K | -204K | -841K | -14.14M | 69K | 708K | 616K | 44K | 84K | -330K |
| Shares Outstanding (Basic) | 138.28M | 106.1M | 78.86M | 51.83M | 39.23M | 33.87M | 28.97M | 26.51M | 22.8M | 10.5M | 20.93M | 20.93M |
| Shares Outstanding (Diluted) | 138.28M | 106.1M | 78.86M | 51.83M | 39.23M | 33.87M | 28.97M | 26.51M | 22.8M | 10.5M | 20.93M | 20.93M |
| EPS (Basic) | -0.7 | -0.54 | -2.05 | -2.36 | -3.82 | -5.3 | -5.06 | -3.85 | -2.43 | -1.83 | -0.25 | -0.16 |
| EPS (Diluted) | -0.7 | -0.54 | -2.05 | -2.36 | -3.82 | -5.3 | -5.06 | -3.85 | -2.43 | -1.83 | -0.25 | -0.16 |
| EBITDA | -110.4M | -58.79M | -152.61M | -117.18M | -143.39M | -200.73M | -153.94M | -100.24M | -54.94M | -18.56M | -5.11M | -3.26M |
| Depreciation & Amortization | n/a | 9.21M | 10.11M | 9.84M | 9.98M | 9.2M | 5.58M | 2.15M | 784K | 594K | 281K | 276K |